Tirzepatida (Mounjaro, Zepbound) Aplicao: 1x por semana Dose mxima: 15 mg um duplo agonista: age no receptor de GLP-1 e no de GIP Resultados: perda de peso de at 21%, maior do que a semaglutida Ambos j foram aprovados por agncias reguladoras para tratar diabetes e obesidade, e esto sendo estudados para muitas outras doenas
Semaglutide imitates the hormones that your body releases when you eat essentially convincing your body that it is full even with smaller portions
Prescribing approach Weekly injections for most GLP-1 protocols Start low, titrate based on response and side effects Ongoing monitoring with our clinical team in Oswego Contraindications (examples) We do not initiate GLP-1 therapy if you have, for example: Personal or family history of medullary thyroid cancer MEN 2 (Multiple Endocrine Neoplasia type 2) Pregnancy or plans to become pregnant History of pancreatitis or severe gastroparesis Full screening happens at consultation
Also, brand name products only FDA approved for the treatment of T2DM, Ozempic and Mounjaro for example, were being prescribed for weight loss in the absence of a T2DM diagnosis
NEWS Preliminary study finds that testosterone levels increase or stabilize in people taking GLP-1 medications